HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Growth hormone and ACTH secretory dynamics in Turner's syndrome.

Abstract
The secretory dynamics of GH and ACTH were studied in 14 patients with Turner's syndrome. The parameters investigated were plasma GH and cortisol responses to hypoglycemia, plasma cortisol circadian rhythm and suppressibility by dexamethasone, and response of urinary Porter-Silber chromogens to metyrapone. The results were mostly normal. These data do not support the hypothesis suggesting an abnormality of hypothalamic-pituitary function in Turner's syndrome.
AuthorsE Reschini, A D'Alberton, A Catania, T Motta
JournalGynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology (Gynecol Endocrinol) Vol. 4 Issue 2 Pg. 119-25 (Jun 1990) ISSN: 0951-3590 [Print] England
PMID2168659 (Publication Type: Journal Article)
Chemical References
  • 17-Hydroxycorticosteroids
  • Adrenocorticotropic Hormone
  • Luteinizing Hormone
  • Follicle Stimulating Hormone
  • Growth Hormone
  • Metyrapone
Topics
  • 17-Hydroxycorticosteroids (blood)
  • Adolescent
  • Adrenocorticotropic Hormone (metabolism)
  • Adult
  • Child
  • Circadian Rhythm
  • Female
  • Follicle Stimulating Hormone (analysis)
  • Genotype
  • Growth Hormone (metabolism)
  • Humans
  • Hypoglycemia (chemically induced, metabolism)
  • Luteinizing Hormone (analysis)
  • Metyrapone (pharmacology)
  • Turner Syndrome (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: